Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis
- PMID: 16306191
- DOI: 10.1203/01.pdr.0000183660.39116.83
Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis
Abstract
Enteropathogenic Escherichia coli (EPEC) is a common pathogen in infantile diarrhea, causing a characteristic histopathologic attaching and effacing (A/E) lesion in the intestinal mucosa. The mouse pathogen Citrobacter rodentium causes a similar A/E lesion in the murine intestine. Like EPEC, C. rodentium infection results in colonic crypt hyperplasia, goblet cell depletion, epithelial proliferation, and mucosal disruption. Using this murine model, we tested the hypothesis that preinoculation of murine gut with Lactobacillus acidophilus early in life can enhance host defense against enteric bacterial infection and attenuate bacteria-mediated colitis. Two-week old BALB/c mice were inoculated with L. acidophilus twice per week for 4 weeks before C. rodentium infection or concomitantly with the exposure to C. rodentium at 6-8 weeks of age. The probiotics were administered twice weekly thereafter. We observed that L. acidophilus inoculation in mice inhibits C. rodentium-induced colitis, which is associated with a decrease in C. rodentium colonization and translocation, an increase in its clearance, and a suppression of colonic myeloperoxidase (MPO) activity. Probiotic treatment also stimulates regulatory cytokine expression in the colon [transforming growth factor beta (TGF-beta), interleukin (IL)-10]. Preinoculation with L. acidophilus is more effective than concomitant use of probiotics in the induction of intestinal IgA secretion and in the downregulation of proinflammatory cytokine expression [tumor necrosis factor alpha (TNF-alpha), IL-6, and IL-12]. These observations suggest that inoculation with probiotics can effectively prevent bacteria-induced colitis by limiting enteric bacteria infection and promoting mucosal protective regulatory immune responses. This study may have ramifications for prevention of infectious diarrhea in human infants and children, particularly in developing countries.
Similar articles
-
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G295-306. doi: 10.1152/ajpgi.00173.2007. Epub 2007 Nov 21. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18032474
-
Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics.J Infect Dis. 2005 Jun 15;191(12):2106-17. doi: 10.1086/430318. Epub 2005 May 11. J Infect Dis. 2005. PMID: 15897997
-
Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.Can J Physiol Pharmacol. 2006 Dec;84(12):1301-12. doi: 10.1139/y06-086. Can J Physiol Pharmacol. 2006. PMID: 17487239
-
Citrobacter rodentium of mice and man.Cell Microbiol. 2005 Dec;7(12):1697-706. doi: 10.1111/j.1462-5822.2005.00625.x. Cell Microbiol. 2005. PMID: 16309456 Review.
-
Citrobacter rodentium: infection, inflammation and the microbiota.Nat Rev Microbiol. 2014 Sep;12(9):612-23. doi: 10.1038/nrmicro3315. Epub 2014 Aug 4. Nat Rev Microbiol. 2014. PMID: 25088150 Review.
Cited by
-
Probiotics manipulate host cytokine response and induce antimicrobial peptides.Folia Microbiol (Praha). 2006;51(5):507-10. doi: 10.1007/BF02931599. Folia Microbiol (Praha). 2006. PMID: 17176775 Review.
-
Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G1115-23. doi: 10.1152/ajpgi.00027.2011. Epub 2011 Feb 24. Am J Physiol Gastrointest Liver Physiol. 2011. PMID: 21350189 Free PMC article.
-
Lactobacillus delbrueckii subsp. lactis (strain CIDCA 133) stimulates murine macrophages infected with Citrobacter rodentium.World J Microbiol Biotechnol. 2017 Mar;33(3):48. doi: 10.1007/s11274-017-2219-4. Epub 2017 Feb 7. World J Microbiol Biotechnol. 2017. PMID: 28176201
-
Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis.Sci Rep. 2022 Oct 20;12(1):17591. doi: 10.1038/s41598-022-21643-0. Sci Rep. 2022. PMID: 36266398 Free PMC article.
-
Polyunsaturated fatty acids modify expression of TGF-β in a co-culture model ultilising human colorectal cells and human peripheral blood mononuclear cells exposed to Lactobacillus gasseri, Escherichia coli and Staphylococcus aureus.Eur J Lipid Sci Technol. 2014 May 12;116(5):505-513. doi: 10.1002/ejlt.201300337. Epub 2014 Mar 31. Eur J Lipid Sci Technol. 2014. PMID: 25598698 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
